Lisa Boyken is the Director and Head of Biometrics at Iambic Therapeutics, where they leverage extensive expertise in oncology trials, including leading successful submissions for supplemental Biologics License Applications (sBLA). Previously, they held roles such as Sr. Biostat II and Sr. Biostat I at Seattle Genetics, overseeing statistical analyses for multiple Phase I, II, and III studies. They earned a PhD in Biostatistics from the University of Washington and a Bachelor of Science in Mathematics from Chapman University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices